Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-12FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Precision Dose, Inc.)
The FDA approved a supplemental application for metformin hydrochloride from Precision Dose, Inc., under an existing abbreviated new drug ap…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy [Phase 3]
A Phase 3 trial evaluating Niaspan for dyslipidemia in patients with diabetic nephropathy was terminated. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Study of REGN1193 in Patients With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 study of REGN1193 in patients with Type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Impact of Sleep and Meal Timing on Food Intake Regulation [NA]
A completed Columbia University clinical trial investigating how sleep and meal timing affect regulation of food intake in obesity, type 2 d…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Pre-meal Protein Drink Improve Glycemic Regulation [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a pre-meal protein drink to improve glycemic regulation in Type 2 Diabetes Mellitus was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) [Phase 4]
Phase 4 trial evaluating safety and efficacy of adding various oral hypoglycemics to sitagliptin + metformin in Chinese patients with type 2…
-
CLINICAL_TRIALS trial_result · 2016-05-11Clinical Trial Update: Diet, Insulin Resistance, and Cardiovascular Risk
This clinical trial update reports on a completed study examining how diet influences insulin resistance and cardiovascular risk.
-
FDA approval · 2016-05-10FDA Approved: GLYBURIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for glyburide from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Cycloset added to metformin versus placebo added to metformin in type 2 diabetes; the st…
-
FDA approval · 2016-05-06FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) submitted by Boehringer Ingelheim Pharm…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: ET-blockade and Exercise-induced Vascular Adaptations in T2DM [Phase 4]
A Phase 4 clinical trial investigating endothelin receptor blockade with exercise-induced vascular adaptations in type 2 diabetes has comple…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients [Phase 4]
A Phase 4 trial evaluating the impact of liraglutide on cardiovascular endpoints in adults with type 2 diabetes; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: ET-blockade and Exercise Induced Blood Flow in T2DM [Phase 4]
A Phase 4 clinical trial investigating endothelin blockade and exercise-induced blood flow in Type 2 Diabetes Mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-03Clinical Trial Update: Effect of Rosuvastatin on Function of High Density Lipoprotein Cholesterol in Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating the effect of rosuvastatin on high-density lipoprotein function in adults with Type 2 diabetes mellitus …
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin [Phase 2]
Pfizer conducted a Phase 2 6-week study to assess the safety and effect of an investigational drug given with canagliflozin in adults with T…
-
CLINICAL_TRIALS research · 2016-05-02Clinical Trial Update: A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin [Phase 2]
Pfizer sponsored a Phase 2 trial to assess the safety and effects of an investigational drug in adults with Type 2 diabetes mellitus taking …
-
FDA approval · 2016-04-29FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin and metformin HCl) from Boehringer Ingelheim Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus [Phase 1]
Phase 1 trial completed comparing BioChaperone Insulin Lispro with Humalog U-100 in adults with Type 2 diabetes, evaluating efficacy, pharma…
-
FDA approval · 2016-04-29FDA Approved: METFORMIN HYDROCHLORIDE EXTENDED RELEASE — Original Application (TIME CAP LABORATORIES, INC)
The FDA approved Time Cap Laboratories, Inc.'s metformin hydrochloride extended-release tablets under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: The Effect of Motivational Short Interview Model in Type 2 Diabetic Patient in Primary Care in TURKEY [NA]
This entry reports a completed study from Marmara University evaluating a motivational short interview model for Type 2 diabetes patients in…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: The Effects of Micronutrients in Combination With Usual Care in Type 2 Diabetes [NA]
This entry notes the completion of a clinical trial evaluating micronutrients added to usual care for Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Exercise in Obese Diabetic Patients With Chronic Kidney Disease [NA]
A completed clinical trial evaluated the effects of structured exercise on outcomes in obese individuals with diabetes and chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State [Phase 1]
A Phase 1 bioequivalence study in healthy fasting subjects involving a diabetes drug candidate has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Interval-training in Type 2 Diabetics [NA]
This clinical trial update notes that a study on interval-training for individuals with Type 2 diabetes has completed. No results are provid…
-
FDA approval · 2016-04-26FDA Approved: GLIPIZIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for the generic drug Glipizide from Apotex Corp.